Acknowledgement
This work was supported by the National Research Foundation, funded by the Korean government's MSIP (2021R1A2C3004572 to J.E.L., 2021R1A6A3A13041249 to H.S.J., 2021R1A4A2001389 to K.W.C., B.O.C., and J.E.L.), and was supported by the National Institutes of Health, USA (NIH RO1 NS094388 to B.O.C. and D.H.K.).
References
- Antonellis, A., Ellsworth, R.E., Sambuughin, N., Puls, I., Abel, A., Lee-Lin, S.Q., Jordanova, A., Kremensky, I., Christodoulou, K., Middleton, L.T., et al. (2003). Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 72, 1293-1299. https://doi.org/10.1086/375039
- Antonellis, A., Lee-Lin, S.Q., Wasterlain, A., Leo, P., Quezado, M., Goldfarb, L.G., Myung, K., Burgess, S., Fischbeck, K.H., and Green, E.D. (2006). Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. J. Neurosci. 26, 10397-10406. https://doi.org/10.1523/jneurosci.1671-06.2006
- Asthana, J., Kapoor, S., Mohan, R., and Panda, D. (2013). Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells. J. Biol. Chem. 288, 22516-22526. https://doi.org/10.1074/jbc.M113.489328
- Banerjee, S. and Riordan, M. (2018). Coordinated regulation of axonal microtubule organization and transport by Drosophila neurexin and BMP pathway. Sci. Rep. 8, 17337. https://doi.org/10.1038/s41598-018-35618-7
- Benoy, V., Van Helleputte, L., Prior, R., d'Ydewalle, C., Haeck, W., Geens, N., Scheveneels, W., Schevenels, B., Cader, M.Z., Talbot, K., et al. (2018). HDAC6 is a therapeutic target in mutant GARS-induced Charcot-MarieTooth disease. Brain 141, 673-687. https://doi.org/10.1093/brain/awx375
- Borg, K. and Ericson-Gripenstedt, U. (2002). Muscle biopsy abnormalities differ between Charcot-Marie-Tooth type 1 and 2: reflect different pathophysiology? Exerc. Sport Sci. Rev. 30, 4-7. https://doi.org/10.1097/00003677-200201000-00002
- Bremer, J., Skinner, J., and Granato, M. (2017). A small molecule screen identifies in vivo modulators of peripheral nerve regeneration in zebrafish. PLoS One 12, e0178854. https://doi.org/10.1371/journal.pone.0178854
- Butler, K.V., Kalin, J., Brochier, C., Vistoli, G., Langley, B., and Kozikowski, A.P. (2010). Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J. Am. Chem. Soc. 132, 10842-10846. https://doi.org/10.1021/ja102758v
- Chapela, D., Sousa, S., Martins, I., Cristovao, A.M., Pinto, P., Corte-Real, S., and Saude, L. (2019). A zebrafish drug screening platform boosts the discovery of novel therapeutics for spinal cord injury in mammals. Sci. Rep. 9, 10475. https://doi.org/10.1038/s41598-019-47006-w
- Chen, S., Owens, G.C., Makarenkova, H., and Edelman, D.B. (2010). HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One 5, e10848. https://doi.org/10.1371/journal.pone.0010848
- Choi, H., Kim, H.J., Yang, J., Chae, S., Lee, W., Chung, S., Kim, J., Choi, H., Song, H., Lee, C.K., et al. (2020). Acetylation changes tau interactome to degrade tau in Alzheimer's disease animal and organoid models. Aging Cell 19, e13081. https://doi.org/10.1111/acel.13081
- Cirrincione, A.M., Pellegrini, A.D., Dominy, J.R., Benjamin, M.E., Utkina-Sosunova, I., Lotti, F., Jergova, S., Sagen, J., and Rieger, S. (2020). Paclitaxel-induced peripheral neuropathy is caused by epidermal ROS and mitochondrial damage through conserved MMP-13 activation. Sci. Rep. 10, 3970. https://doi.org/10.1038/s41598-020-60990-8
- Cirrincione, A.M. and Rieger, S. (2020). Analyzing chemotherapy-induced peripheral neuropathy in vivo using non-mammalian animal models. Exp. Neurol. 323, 113090. https://doi.org/10.1016/j.expneurol.2019.113090
- Dompierre, J.P., Godin, J.D., Charrin, B.C., Cordelieres, F.P., King, S.J., Humbert, S., and Saudou, F. (2007). Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J. Neurosci. 27, 3571-3583. https://doi.org/10.1523/JNEUROSCI.0037-07.2007
- d'Ydewalle, C., Krishnan, J., Chiheb, D.M., Van Damme, P., Irobi, J., Kozikowski, A.P., Vanden Berghe, P., Timmerman, V., Robberecht, W., and Van Den Bosch, L. (2011). HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat. Med. 17, 968-974. https://doi.org/10.1038/nm.2396
- Ennerfelt, H., Voithofer, G., Tibbo, M., Miller, D., Warfield, R., Allen, S., and Kennett Clark, J. (2019). Disruption of peripheral nerve development in a zebrafish model of hyperglycemia. J. Neurophysiol. 122, 862-871. https://doi.org/10.1152/jn.00318.2019
- Grice, S.J., Sleigh, J.N., Motley, W.W., Liu, J.L., Burgess, R.W., Talbot, K., and Cader, M.Z. (2015). Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology. Hum. Mol. Genet. 24, 4397-4406. https://doi.org/10.1093/hmg/ddv176
- Ha, N., Choi, Y.I., Jung, N., Song, J.Y., Bae, D.K., Kim, M.C., Lee, Y.J., Song, H., Kwak, G., Jeong, S., et al. (2020). A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A. Br. J. Pharmacol. 177, 5096-5113. https://doi.org/10.1111/bph.15231
- He, W., Bai, G., Zhou, H., Wei, N., White, N.M., Lauer, J., Liu, H., Shi, Y., Dumitru, C.D., Lettieri, K., et al. (2015). CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase. Nature 526, 710-714. https://doi.org/10.1038/nature15510
- Holloway, M.P., DeNardo, B.D., Phornphutkul, C., Nguyen, K., Davis, C., Jackson, C., Richendrfer, H., Creton, R., and Altura, R.A. (2016). An asymptomatic mutation complicating severe chemotherapy-induced peripheral neuropathy (CIPN): a case for personalised medicine and a zebrafish model of CIPN. NPJ Genom. Med. 1, 16016. https://doi.org/10.1038/npjgenmed.2016.16
- Howard, J.F., Jr. (2018). Myasthenia gravis: the role of complement at the neuromuscular junction. Ann. N. Y. Acad. Sci. 1412, 113-128. https://doi.org/10.1111/nyas.13522
- Janke, C. and Bulinski, J.C. (2011). Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions. Nat. Rev. Mol. Cell Biol. 12, 773-786. https://doi.org/10.1038/nrm3227
- Jung, J., Choi, I., Ro, H., Huh, T.L., Choe, J., and Rhee, M. (2020). march5 governs the convergence and extension movement for organization of the telencephalon and diencephalon in zebrafish embryos. Mol. Cells 43, 76-85. https://doi.org/10.14348/molcells.2019.0210
- Kalebic, N., Martinez, C., Perlas, E., Hublitz, P., Bilbao-Cortes, D., Fiedorczuk, K., Andolfo, A., and Heppenstall, P.A. (2013). Tubulin acetyltransferase alphaTAT1 destabilizes microtubules independently of its acetylation activity. Mol. Cell. Biol. 33, 1114-1123. https://doi.org/10.1128/MCB.01044-12
- Kesner, V.G., Oh, S.J., Dimachkie, M.M., and Barohn, R.J. (2018). Lambert-Eaton myasthenic syndrome. Neurol. Clin. 36, 379-394. https://doi.org/10.1016/j.ncl.2018.01.008
- Lee, H.J., Park, J., Nakhro, K., Park, J.M., Hur, Y.M., Choi, B.O., and Chung, K.W. (2012). Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V. J. Peripher. Nerv. Syst. 17, 418-421. https://doi.org/10.1111/j.1529-8027.2012.00442.x
- Licciardi, P.V. and Karagiannis, T.C. (2012). Regulation of immune responses by histone deacetylase inhibitors. ISRN Hematol. 2012, 690901. https://doi.org/10.5402/2012/690901
- Loprest, L.J., Pericak-Vance, M.A., Stajich, J., Gaskell, P.C., Lucas, A.M., Lennon, F., Yamaoka, L.H., Roses, A.D., and Vance, J.M. (1992). Linkage studies in Charcot-Marie-Tooth disease type 2: evidence that CMT types 1 and 2 are distinct genetic entities. Neurology 42(3 Pt 1), 597-601. https://doi.org/10.1212/WNL.42.3.597
- Mann, B.S., Johnson, J.R., Cohen, M.H., Justice, R., and Pazdur, R. (2007). FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 12, 1247-1252. https://doi.org/10.1634/theoncologist.12-10-1247
- Mariadason, J.M. (2008). HDACs and HDAC inhibitors in colon cancer. Epigenetics 3, 28-37. https://doi.org/10.4161/epi.3.1.5736
- Menelaou, E., Husbands, E.E., Pollet, R.G., Coutts, C.A., Ali, D.W., and Svoboda, K.R. (2008). Embryonic motor activity and implications for regulating motoneuron axonal pathfinding in zebrafish. Eur. J. Neurosci. 28, 1080-1096. https://doi.org/10.1111/j.1460-9568.2008.06418.x
- Mo, Z., Zhao, X., Liu, H., Hu, Q., Chen, X.Q., Pham, J., Wei, N., Liu, Z., Zhou, J., Burgess, R.W., et al. (2018). Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy. Nat. Commun. 9, 1007. https://doi.org/10.1038/s41467-018-03461-z
- Morena, J., Gupta, A., and Hoyle, J.C. (2019). Charcot-Marie-Tooth: from molecules to therapy. Int. J. Mol. Sci. 20, 3419. https://doi.org/10.3390/ijms20143419
- Namdar, M., Perez, G., Ngo, L., and Marks, P.A. (2010). Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents. Proc. Natl. Acad. Sci. U. S. A. 107, 20003-20008. https://doi.org/10.1073/pnas.1013754107
- Niehues, S., Bussmann, J., Steffes, G., Erdmann, I., Kohrer, C., Sun, L., Wagner, M., Schafer, K., Wang, G., Koerdt, S.N., et al. (2015). Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases. Nat. Commun. 6, 7520. https://doi.org/10.1038/ncomms8520
- Osseni, A., Ravel-Chapuis, A., Thomas, J.L., Gache, V., Schaeffer, L., and Jasmin, B.J. (2020). HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions. J. Cell Biol. 219, e201901099. https://doi.org/10.1083/jcb.201901099
- Ponomareva, O.Y., Eliceiri, K.W., and Halloran, M.C. (2016). Charcot-Marie-Tooth 2b associated Rab7 mutations cause axon growth and guidance defects during vertebrate sensory neuron development. Neural Dev. 11, 2. https://doi.org/10.1186/s13064-016-0058-x
- Rodriguez Cruz, P.M., Cossins, J., Beeson, D., and Vincent, A. (2020). The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis. Front. Mol. Neurosci. 13, 610964. https://doi.org/10.3389/fnmol.2020.610964
- Seburn, K.L., Nangle, L.A., Cox, G.A., Schimmel, P., and Burgess, R.W. (2006). An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 51, 715-726. https://doi.org/10.1016/j.neuron.2006.08.027
- Simoes-Pires, C., Zwick, V., Nurisso, A., Schenker, E., Carrupt, P.A., and Cuendet, M. (2013). HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol. Neurodegener. 8, 7. https://doi.org/10.1186/1750-1326-8-7
- Sivakumar, K., Kyriakides, T., Puls, I., Nicholson, G.A., Funalot, B., Antonellis, A., Sambuughin, N., Christodoulou, K., Beggs, J.L., Zamba-Papanicolaou, E., et al. (2005). Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 128, 2304-2314. https://doi.org/10.1093/brain/awh590
- Sleigh, J.N., Dawes, J.M., West, S.J., Wei, N., Spaulding, E.L., Gomez-Martin, A., Zhang, Q., Burgess, R.W., Cader, M.Z., Talbot, K., et al. (2017). Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by Gars mutations. Proc. Natl. Acad. Sci. U. S. A. 114, E3324-E3333.
- Sleigh, J.N., Grice, S.J., Burgess, R.W., Talbot, K., and Cader, M.Z. (2014). Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice. Hum. Mol. Genet. 23, 2639-2650. https://doi.org/10.1093/hmg/ddt659
- Sleigh, J.N., Mech, A.M., and Schiavo, G. (2020). Developmental demands contribute to early neuromuscular degeneration in CMT2D mice. Cell Death Dis. 11, 564. https://doi.org/10.1038/s41419-020-02798-y
- Smith, A., Kim, J.H., Chun, C., Gharai, A., Moon, H.W., Kim, E.Y., Nam, S.H., Ha, N., Song, J.Y., Chung, K.W., et al. (2022). HDAC6 inhibition corrects electrophysiological and axonal transport deficits in a human stem cell-based model of Charcot-Marie-Tooth disease (type 2D). Adv. Biol. (Weinh.) 6, e2101308.
- Son, I.H., Chung, I.M., Lee, S.I., Yang, H.D., and Moon, H.I. (2007). Pomiferin, histone deacetylase inhibitor isolated from the fruits of Maclura pomifera. Bioorg. Med. Chem. Lett. 17, 4753-4755. https://doi.org/10.1016/j.bmcl.2007.06.060
- Valenzuela-Fernandez, A., Cabrero, J.R., Serrador, J.M., and Sanchez-Madrid, F. (2008). HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol. 18, 291-297. https://doi.org/10.1016/j.tcb.2008.04.003
- Vilmont, V., Cadot, B., Vezin, E., Le Grand, F., and Gomes, E.R. (2016). Dynein disruption perturbs post-synaptic components and contributes to impaired MuSK clustering at the NMJ: implication in ALS. Sci. Rep. 6, 27804. https://doi.org/10.1038/srep27804
- Wenzel, E.D., Speidell, A., Flowers, S.A., Wu, C., Avdoshina, V., and Mocchetti, I. (2019). Histone deacetylase 6 inhibition rescues axonal transport impairments and prevents the neurotoxicity of HIV-1 envelope protein gp120. Cell Death Dis. 10, 674. https://doi.org/10.1038/s41419-019-1920-7
- Wong, V.S.C., Picci, C., Swift, M., Levinson, M., Willis, D., and Langley, B. (2018). alpha-tubulin acetyltransferase is a novel target mediating neurite growth inhibitory effects of chondroitin sulfate proteoglycans and myelin-associated glycoprotein. eNeuro 5, ENEURO.0240-17.2018.
- Zhang, Y., Li, N., Caron, C., Matthias, G., Hess, D., Khochbin, S., and Matthias, P. (2003). HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 22, 1168-1179. https://doi.org/10.1093/emboj/cdg115